Abstract
In phase-I clinical trials of adoptive immunotherapy using lymphokine-activated killer (LAK) cells plus recombinant interleukin-2 (rIL-2) (Cetus) for the treatment of malignant glioma, we observed that blood mononuclear cells (MNC) from patients dependent on dexamethasone for management of cerebral edema produced substantially less LAK activity as compared to MNC of normal blood donors or glioma patients not receiving steroid therapy. Therefore, we examined the in vitro effects, brought about by therapeutically attainable concentrations of various corticosteroids, on the proliferative response, production of gamma interferon (IFN-gamma), and induction of LAK activity from blood MNC of normal donors. Incubation in media containing rIL-2 (1000 U/ml) with either dexamethasone, hydrocortisone, methylprednisolone, or prednisolone profoundly affected all of these parameters. First, while 0.01 micrograms/ml of either dexamethasone or hydrocortisone caused a slight enhancement of the mitogenic response of lymphocytes to phytohemagglutinin, a dose-dependent decline occurred as concentrations increased to 10 micrograms/ml. The addition of prednisolone and methylprednisolone elicited a dose-dependent inhibition of lymphocyte proliferation...Continue Reading
Citations
Sep 1, 1995·Brain Research. Brain Research Reviews·M Weller, A Fontana
Nov 1, 1995·Brain Research. Brain Research Reviews·U K Hanisch, R Quirion
Dec 1, 1993·Veterinary Immunology and Immunopathology·T Isobe, H S Lillehoj
Oct 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G MantovaniP Lai
Feb 1, 1997·Brain Research. Brain Research Reviews·B S McEwenJ M Weiss
Oct 1, 1993·Annals of Surgery·S GalandiukH C Polk
Feb 1, 1992·Journal of Neurosurgery·D W McVicarR E Merchant
Nov 1, 1992·Journal of Neurosurgery·T L RoszmanW H Brooks
Apr 18, 2002·Journal of Neuroimmunology·Mieke BuntinxPiet Stinissen
Oct 20, 2009·Journal of Psychosomatic Research·Bonnie B BlombergMichael H Antoni
Jan 1, 1992·Clinical Immunology and Immunopathology·M T Lotze
Oct 10, 2009·Journal of Immunotherapy·Robert Owen DillmanMadeline Carol DePriest
Apr 4, 2001·Allergy·G Di LorenzoC Caruso
Mar 1, 1992·Cellular Immunology·D W McVicarR E Merchant